Additionally, the VACV-expressed IFN-γ binding protein (IFN-γ BP) has a low affinity for murine IFN-γ [61], making the availability of murine IFN-γ higher when used for treatment of a VACV-WR infection. This evidence concerns the gene IFNG and infection.